Robert Yalden is a partner in Osler’s Montreal office. He is co-chair of the firm’s national mergers and acquisitions group and head of the Montreal office’s corporate group. His career with Osler spans over 25 years, during which he has been involved with some of Canada’s most innovative and groundbreaking transactions. Mr Yalden has advised boards of directors and senior management in connection with a wide range of corporate governance and M&A mandates. He was part of the Osler team that implemented the first poison pill in Canada. He led the Osler legal teams involved in Canada’s largest-ever completed leveraged buyout, as well as the largest private equity deals in Quebec in 2014 and 2015. He has recently been involved with a significant proxy fight that has seen the problems of ‘empty voting’ on the part of hedge funds receive considerable public scrutiny in Canada. He is the co-author of Business Organizations: Practice, Theory and Emerging Challenges (2018) and is an adjunct professor at McGill University Faculty of Law, where he teaches a course in comparative corporate governance.